IRulya Therapeutics, Inc. (IRLA)
32.95
+1.33
(+4.21%)
USD |
NASDAQ |
Oct 30, 16:00
33.50
+0.55
(+1.67%)
After-Hours: 20:00
IRulya Therapeutics Market Cap : 33.51M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 33.51M |
| October 29, 2026 | 32.16M |
| October 28, 2026 | 33.52M |
| October 27, 2026 | 33.03M |
| October 26, 2026 | 31.92M |
| October 23, 2026 | 33.65M |
| October 22, 2026 | 33.39M |
| October 21, 2026 | 35.27M |
| October 20, 2026 | 40.96M |
| October 19, 2026 | 35.04M |
| October 16, 2026 | 32.58M |
| October 15, 2026 | 33.80M |
| October 14, 2026 | 30.51M |
| October 13, 2026 | 28.35M |
| October 12, 2026 | 32.95M |
| October 09, 2026 | 32.27M |
| October 08, 2026 | 29.86M |
| October 07, 2026 | 27.18M |
| October 06, 2026 | 27.27M |
| October 05, 2026 | 28.58M |
| October 02, 2026 | 29.70M |
| October 01, 2026 | 31.20M |
| September 30, 2026 | 31.54M |
| September 29, 2026 | 31.70M |
| September 28, 2026 | 29.50M |
| Date | Value |
|---|---|
| September 25, 2026 | 31.53M |
| September 24, 2026 | 30.51M |
| September 23, 2026 | 30.67M |
| September 22, 2026 | 31.89M |
| September 21, 2026 | 31.53M |
| September 18, 2026 | 29.98M |
| September 17, 2026 | 27.47M |
| September 16, 2026 | 27.63M |
| September 15, 2026 | 29.34M |
| September 14, 2026 | 29.08M |
| September 11, 2026 | 30.06M |
| September 10, 2026 | 29.46M |
| September 09, 2026 | 30.83M |
| September 08, 2026 | 30.00M |
| September 04, 2026 | 31.86M |
| September 03, 2026 | 31.07M |
| September 02, 2026 | 32.70M |
| September 01, 2026 | 32.66M |
| August 31, 2026 | 33.13M |
| August 28, 2026 | 34.33M |
| August 27, 2026 | 33.06M |
| August 26, 2026 | 31.85M |
| August 25, 2026 | 31.46M |
| August 24, 2026 | 34.05M |
| August 21, 2026 | 34.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Korsana Biosciences, Inc. | 18.33M |
| PepGen Inc. | 163.45M |
| Q32 Bio, Inc. | 211.49M |
| Bridgebio Oncology Therapeutics, Inc. | 209.90M |
| Arrowhead Pharmaceuticals, Inc. | 8.454B |
Market Cap Related Metrics
| Price | 32.95 |
| Earnings Yield | -381.2% |